Home
Radiology Guides Anatomy Physio & Path Medicine Physics Contact
NOAC-AF & VALVULAR HEART DISEASE

Haematology

NOAC-AF & VALVULAR HEART DISEASE

1. Patients with AF & haemodynamically significant valvular heart disease were excluded from the trials evaluating the NOACs.

2. Warfarin remains the standard of care for these patients and, until further studies are performed, NOACs are not recommended.

3. Patients with prosthetic valves represent a particularly high-risk group for whom warfarin has been the mainstay of therapy.


Avatar
REFERENCES

1. Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
2. Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
3. Image: no reference available.

Ⓒ A. Manickam 2018

+ Home